Background: Safe and effective delivery of inhaled nitric oxide (INO) requires the appropriate interface of ventilator and INO delivery device.
Methods: We compared INO delivery using four configurations with the Transport Sinusoidal Bronchotron® and INOmax DSIR Plus in a lung model. Ventilator settings and lung model values were held constant. Delivered NO, NO , and inspired oxygen (FIO ) were measured. The mean difference between set and measured NO was calculated and compared using ANOVA.
Results: Placement of the injector module in line with the sliding venturi resulted in a ventilator failure. With both continuous flow techniques there was no appreciable NO generated and the mean difference between set NO and measured NO at 20 and 40 ppm was -16.5 ppm and -33.2 ppm at flows of 5 and 10 L/min. Placement of the injector module between the sliding venturi and lung model resulted in an increase of NO2 to a peak of 2.4 ppm (mean 2.3 + 0.1) and a mean difference between set and measured NO of + 11.3 ppm and +30 ppm at 20 and 40 ppm, 300 cycles per minute (cpm), and 22.1 ppm and 37.6 ppm, at 20 and 40 ppm, 600 cpm. None of the test configurations delivered INO within 30% of set concentrations. No alarms or interruption of INO delivery occurred.
Conclusion: The dual gas delivery system of the Bronchotron prevents accurate delivery of INO. The combination of these two devices should be accomplished with caution and vigilance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ppul.23934 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Scalable Manufacturing Method for Model Protein-Loaded PLGA Nanoparticles: Biocompatibility, Trafficking and Release Properties.
Pharmaceutics
January 2025
MyBiotech GmbH, Industriestraße 1B, 66802 Überherrn, Germany.
: Drug delivery systems (DDSs) offer efficient treatment solutions to challenging diseases such as central nervous system (CNS) diseases by bypassing biological barriers such as the blood-brain barrier (BBB). Among DDSs, polymeric nanoparticles (NPs), particularly poly(lactic-co-glycolic acid) (PLGA) NPs, hold an outstanding position due to their biocompatible and biodegradable qualities. Despite their potential, the translation of PLGA NPs from laboratory-scale production to clinical applications remains a significant challenge.
View Article and Find Full Text PDFInnovative Approaches to Enhancing the Biomedical Properties of Liposomes.
Pharmaceutics
November 2024
Department of Surgical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 10 Piata 1 Decembrie Street, 410073 Oradea, Romania.
Liposomes represent a promising class of drug delivery systems that enhance the therapeutic efficacy and safety of various pharmaceutical agents. Also, they offer numerous advantages compared to traditional drug delivery methods, including targeted delivery to specific sites, controlled release, and fewer side effects. This review meticulously examines the methodologies employed in the preparation and characterization of liposomal formulations.
View Article and Find Full Text PDFPrecipitation Polymerization-Based Molecularly Imprinted Polymers: A Novel Approach for Transdermal Curcumin Delivery.
Polymers (Basel)
December 2024
Department of Biology, Faculty of Science and Mathematics, Diponegoro University, Jl. Prof. Soedharto SH, Tembalang, Semarang 50275, Indonesia.
This research describes the synthesis and characterization of a molecularly imprinted polymer (MIP) as a candidate for the transdermal delivery of curcumin. The MIP was synthesized through precipitation polymerization using methacrylic acid as the functional monomer and ethylene glycol dimethacrylate as the cross-linking agent. MIP characterization studies were conducted using SEM-EDX and FTIR spectroscopy to determine the morphology and interaction between curcumin and polymers.
View Article and Find Full Text PDFSolid-State Gas Sensors with Ni-Based Sensing Materials for Highly Selective Detecting NOx.
Sensors (Basel)
November 2024
Institute of Micro-Nano Science and Technology & National Key Laboratory of Advanced Micro and Nano Manufacture Technology, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Precise monitoring of NO concentrations in nitric oxide delivery systems is crucial to ensure the safety and well-being of patients undergoing inhaled nitric oxide (iNO) therapy for pulmonary arterial hypertension. Currently, NO sensing in commercialized iNO instruments predominantly relies on chemiluminescence sensors, which not only drives up costs but also limits their portability. Herein, we developed solid-state gas sensors utilizing Ni-based sensing materials for effectively tracking the levels of NO and NO in the NO delivery system.
View Article and Find Full Text PDFFeasibility of controlled nitric oxide generation ascorbate induced chemical reduction of nitrite ions.
Dalton Trans
November 2024
Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA.
Inhalable nitric oxide (iNO) is a lifesaving, FDA-approved drug to improve oxygenation in persistent pulmonary hypertension of the newborn. iNO also has many other applications in lung diseases owing to its vasodilatory and antimicrobial effects. However, its wider therapeutic application is often prohibited by the high cost and logistical barriers of traditional NO/N gas tanks.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!